You are here: Industry Insights > Clinical Trial

News List

Immix Receives FDA Authorization to Expand Clinical Trial americanpharmaceuticalreview
July 25, 2019
Immix Biopharma announced it received a letter from the FDA authorizing it to proceed with expanding its phase 1b/2a clinical trial of IMX-110 to the United States under an IND. IMX-110 is a first-in-class combination therapy designed to inhibit cancer re
CVS Health Announces Clinical Trial for New Home Hemodialysis Device americanpharmaceuticalreview
July 18, 2019
CVS Health announced the initiation of a clinical trial designed to evaluate the safety and efficacy of the HemoCare™ Hemodialysis System for administration of home hemodialysis.
Neurotrope Concludes Data Collection in Alzheimer's Disease Clinical Trial americanpharmaceuticalreview
July 16, 2019
Neurotrope announced that the Company has concluded data collection in its confirmatory Phase 2 double blind, placebo controlled clinical trial of Bryostatin-1 in the treatment of moderately severe to severe AD.
Mirum Initiates Maralixibat Phase 3 Clinical Trial americanpharmaceuticalreview
July 10, 2019
Mirum Pharmaceuticals announced the dosing of the first patient in the Phase 3 MARCH-PFIC clinical trial of its lead drug candidate, maralixibat, in pediatric patients with progressive familial intrahepatic cholestasis (PFIC).
Cyxone Submits First Application to Start Rabeximod Clinical Trial americanpharmaceuticalreview
July 08, 2019
Cyxone has submitted an application to the Central Ethics Committee (CEC) in Poland for permission to start a clinical phase IIb trial with its drug candidate Rabeximod, which is in development for the treatment of rheumatoid arthritis (RA).
Biohaven Enrolls First Patient in Rimegepant Phase 2 Clinical Trial americanpharmaceuticalreview
July 03, 2019
Biohaven announced that the first patient has been enrolled in a Phase 2 clinical trial assessing the efficacy and safety of rimegepant in treatment refractory trigeminal neuralgia.
SpringWorks and GSK sign clinical trial collaboration agreement pharmaceutical-technology
July 01, 2019
SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s (GSK) belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma.
Tricida Announces Publication of Positive Long-Term Phase 3 Clinical Trial Results of Veverimer (TRC101) in The Lancet drugs
June 28, 2019
Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed ...
Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (“GEM-2 study”) of KB103 and Receives Regenerative Medicine Advanced Therapy (“RMAT”) Designation from FDA for KB103 drugs
June 28, 2019
Krystal Biotech, Inc. (Nasdaq: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from rare dermatological diseases ...
I-Mab Announces Dosing of First Patient in a Phase I Clinical Trial of TJC4 americanpharmaceuticalreview
June 26, 2019
I-Mab Biopharma announced the first patient has been dosed in a Phase I clinical trial of TJC4. The study is known as TJ011133 (NCT Number: NCT03934814).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page